Is low molecular weight heparin a neuroprotectant?

被引：42

作者：

Jonas, S ^{[1
]}

Sugimori, M ^{[1
]}

Llinas, R ^{[1
]}

机构：

[1] NYU, SCH MED, DEPT PHYSIOL & NEUROSCI, NEW YORK, NY 10016 USA

来源：

NEUROPROTECTIVE AGENTS - THIRD INTERNATIONAL CONFERENCE | 1997年 / 825卷

关键词：

D O I：

10.1111/j.1749-6632.1997.tb48449.x

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：389 / 393

页数：5

共 8 条

[1]

BLACK SC, 1995, CARDIOVASC RES, V29, P629, DOI 10.1016/0008-6363(96)88632-9

[2] INTRAVENOUS HEPARIN FOR THE PREVENTION OF STROKE PROGRESSION IN ACUTE PARTIAL STABLE STROKE - A RANDOMIZED CONTROLLED TRIAL [J].

DUKE, RJ ;

BLOCH, RF ;

TURPIE, AGG ;

TREBILCOCK, R ;

BAYER, N .

ANNALS OF INTERNAL MEDICINE, 1986, 105 (06) :825-828

[3] EFFECTS OF HEPARIN AND N-ACETYL HEPARIN ON ISCHEMIA/REPERFUSION-INDUCED ALTERATIONS IN MYOCARDIAL-FUNCTION IN THE RABBIT ISOLATED HEART [J].

FRIEDRICHS, GS ;

KILGORE, KS ;

MANLEY, PJ ;

GRALINSKI, MR ;

LUCCHESI, BR .

CIRCULATION RESEARCH, 1994, 75 (04) :701-710

[4] LOW-MOLECULAR-WEIGHT HEPARIN FOR THE TREATMENT OF ACUTE ISCHEMIC STROKE [J].

KAY, R ;

WONG, KS ;

YU, YL ;

CHAN, YW ;

TSOI, TH ;

AHUJA, AT ;

CHAN, FL ;

FONG, KY ;

LAW, CB ;

WONG, A ;

WOO, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1588-1593

[5] DEFINED GLYCOSAMINOGLYCAN MOTIFS HAVE OPPOSITE EFFECTS ON NEURONAL POLARITY IN-VITRO [J].

LAFONT, F ;

PROCHIANTZ, A ;

VALENZA, C ;

PETITOU, M ;

PASCAL, M ;

ROUGET, M ;

ROUSSELET, A .

DEVELOPMENTAL BIOLOGY, 1994, 165 (02) :453-468

[6] CAN SIMPLE QUESTIONS ASSESS OUTCOME AFTER STROKE [J].

LINDLEY, RI ;

WADDELL, F ;

LIVINGSTONE, M ;

SANDERCOCK, P ;

DENNIS, MS ;

SLATTERY, J ;

SMITH, B ;

WARLOW, C .

CEREBROVASCULAR DISEASES, 1994, 4 (04) :314-324

[7]

LLINAS R, 1990, FID RES FDN, V4, P1

[8]

Sugimori M., 1995, Society for Neuroscience Abstracts, V21, P2019

← 1 →